Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gut microbiota and metabolites analysis in serum

ABSTRACT: Gut-microbiota-brain axis involves in the neuroprotection of phosphoglycerate mutase 5 deficiency in traumatic brain injury mice

PROVIDER: PRJNA973850 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

gut microbiota and metabolites analysis in serum

Project description:Gut-microbiota-brain axis involves in the neuroprotection of phosphoglycerate mutase 5 deficiency in traumatic brain injury mice

| PRJNA741415 | ENA

Sumoylation-deficient phosphoglycerate mutase 2 impairs myogenic differentiation

Project description:Sumoylation-deficient phosphoglycerate mutase 2 impairs myogenic differentiation

| PRJNA909295 | ENA

Comparative proteomic analysis for a putative 2, 3-bisphosphoglycerate-dependent phosphoglycerate mutase in Acidovorax citrulli

Project description:- Identification of proteins whose expression was affected by a putative 2, 3-bisphosphoglycerate-dependent phosphoglycerate mutase in Acidovorax citrulli str. KACC17005 - Shotgun proteomic analysis was used - Two strains were used with three biological replicates (total 6 samples). WT: the wild-type strain. 2H: 2, 3-bisphosphoglycerate-dependent phosphoglycerate mutase knockout mutant

2022-10-24 | PXD035156 | Pride

Saccharomyces cerevisiae

Project description:Phosphoglycerate mutase knock-out mutant Saccharomyces cerevisiae: physiological investigation and transcriptome analysis

| PRJNA127587 | ENA

Mesenchymal stromal cell secretome and its key bioactive metabolites induce long-term neuroprotection after traumatic brain injury in mice

Project description:Mesenchymal stromal cell secretome and its key bioactive metabolites induce long-term neuroprotection after traumatic brain injury in mice

| PRJEB87270 | ENA

Project description:Probiotic treatment causes sex-specific neuroprotection after traumatic brain injury in mice

| PRJNA1095399 | ENA

mtROS-driven Sp1-dependent retrograde signaling promotes colorectal tumor progression via SIRT3-PAGM5 axis-governed mitochondrial homeostasis

Project description:Mitochondrial-nuclear communication is critical for maintaining mitochondrial integrity and cellular metabolic adaptation. While mitochondrial dysfunction triggers compensatory retrograde signaling, the molecular mechanisms underlying defect sensing and resolution remain poorly defined. Here, we demonstrated that mitochondrial reactive oxygen species (mtROS) trigger Sp1 stabilization and nuclear translocation, which directly activate transcription of the NAD+-dependent deacetylase SIRT3 through specific promoter binding, revealing a redox-sensitive regulatory axis controlling mitochondrial homeostasis. Mechanistically, SIRT3 sustains mitochondrial integrity through site-specific deacetylation (K141) of mitochondrial phosphoglycerate mutase 5 (PGAM5). Furthermore, SIRT3-mediated deacetylation of PGAM5 was instrumental in promoting Pink1/parkin-dependent mitophagy, thereby maintaining mitochondrial homeostasis. Alternatively, we identified the mitochondrial-nuclear retrograde signaling cascade comprising Sp1, SIRT3 and PGAM5 as a novel driver of colorectal tumorigenesis. Taken together, our findings reveal that mtROS act as pivotal signaling mediators linking mitochondrial perturbations to the nuclear transcriptional adaptation response via the Sp1-SIRT3-PGAM5 retrograde signaling axis. This retrograde signaling cascade enables adaptive transcriptional reprogramming to restore mitochondrial homeostasis, thereby endowing tumor cells with increased stress tolerance.

2025-11-01 | GSE305053 | GEO

Phosphoglycerate mutase regulates Treg differentiation through control of serine synthesis and one-carbon metabolism

Project description:Phosphoglycerate mutase regulates Treg differentiation through control of serine synthesis and one-carbon metabolism

| PRJNA1124004 | ENA

NanoString analysis of mouse brain endothelial cells in response to peripheral LPS treatment.

Project description:Four daily intraperitoneal injections of the Gram-negative bacterial endotoxin lipopolysaccharide (LPS) transiently protects the cerebral cortex against traumatic brain injury. Underlying mechanisms associated with this neuroprotection include increased neuronal production of anti-apoptotic and neurotrophic molecules, microglial-mediated displacement of inhibitory presynaptic terminals innervating the soma of cortical projection neurons, and synchronized firing of cortical projection neurons. The molecular mechanisms responsible for inducing this neuroprotection and microglial activation are unknown. A fundamental question is whether LPS enters the central nervous system (CNS) or mediates it actions on the luminal surface of brain endothelial cells. In this study, we demonstrate that LPS injected into the peritoneum does not enter the CNS or alter tight junctions of brain endothelial cells. However, LPS activation of vascular endothelial cells was substantiated by increased expression of activation markers (CD54 and CD105) and the LPS receptor, TLR4, on CD31-positive brain endothelial cells isolated by flow cytometry. Transcript analyses further revealed significant upregulation of Cxcl10, C3, Ccl2, Il1b, Cxcl2, and Cxcl1 in these activated endothelial cells, consistent with identification of MyD88 as a regulator of these transcripts by pathway analysis. Using conditional brain endothelial gene ablation strategies, we establish that MyD88-dependent endothelial TLR4 signaling and endothelial Cxcl10 expression are essential for LPS-induced neuroprotection and microglial activation. CXCL10 production by brain endothelial cells in response to circulating TLR ligands thus provides a pathway to directly or indirectly signal to CXCR3 on neurons and/or microglia. Targeting activation of brain endothelial receptors provides an attractive and practical approach for inducing transient neuroprotection.

2022-02-01 | GSE193015 | GEO

Rattus norvegicus

Project description:Traumatic brain injury

| PRJNA1065340 | ENA